Abstract
Rosacea is difficult to treat. Therefore, new alternative modalities are necessary to demonstrate. The present study was conducted to assess the efficacy and safety of the combined therapy of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) and intense pulsed light (IPL) for rosacea to provide a new treatment option for rosacea. The study was conducted from November 2017 to April 2019 at the Department of Dermatology, The First Hospital of China Medical University. Patients aged 18–65 years and diagnosed clinically as erythematotelangiectatic (ET) or papulopustular (PP) rosacea were enrolled. Three times of ALA-PDT at 10 days interval followed by 3 times of IPL at 3–4 weeks interval were defined as 1 session and applied to the whole face of each patient. ALA-PDT: 5% ALA, red light (fluency dose 60–100 mW/cm2, 20 min); IPL: 560/590/640 nm, double/triple-pulse mode, pulse width 3.0 to 4.5 ms, delay time 30–40 ms, energy fluency 14–17 J/cm2. Ten patients were enrolled in the study. Among them, 4 patients received only 1 session, while 6 patients received 2 sessions. After all treatments, 50% of patients achieved 75–100% improvement, and 30% achieved 50–75% improvement. Forty percent of patients were graded very satisfaction and 30% graded moderate satisfaction. All noninvasive measurements showed no significant differences among all time points (p > 0.05). The side effects were pain, burning sensation, itching, erythema, desquamation, slight edema, slight exudation, and hyperpigmentation. All of which were tolerable and recovered in a few days. The combined therapy of ALA-PDT and IPL showed an effective option for rosacea with a safety profile.
Similar content being viewed by others
Data Availability
All data are available on request to corresponding author.
References
van Zuuren EJ, Fedorowicz Z (2015) Interventions for rosacea. JAMA 314:2403–2404. https://doi.org/10.1001/jama.2015.15287
Schaller M, Schofer H, Homey B, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M (2016) State of the art: systemic rosacea management. J Dtsch Dermatol Ges 14(Suppl 6):29–37. https://doi.org/10.1111/ddg.13141
Crawford GH, Pelle MT, James WD (2004) Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51:327–341. https://doi.org/10.1016/j.jaad.2004.03.030
Meyer-Hoffert U, Schroder JM (2011) Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc 15:16–23. https://doi.org/10.1038/jidsymp.2011.2
Georgala S, Katoulis AC, Kylafis GD, Koumantaki-Mathioudaki E, Georgala C, Aroni K (2001) Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol 15:441–444. https://doi.org/10.1046/j.1468-3083.2001.00331.x
Hofmann MA, Lehmann P (2016) Physical modalities for the treatment of rosacea. J Dtsch Dermatol Ges 14(Suppl 6):38–43. https://doi.org/10.1111/ddg.13144
Steinhoff M, Schauber J, Leyden JJ (2013) New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 69:S15–S26. https://doi.org/10.1016/j.jaad.2013.04.045
Aubdool AA, Brain SD (2011) Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc 15:33–39. https://doi.org/10.1038/jidsymp.2011.8
Tan J, Almeida LMC, Bewley A, Cribier B, Dlova NC, Gallo R, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren EJ, Schaller M (2017) Updating the diagnosis, classification and assessment of rosacea: recommendations from the global rosacea consensus (ROSCO) panel. Bri J Dermatol 176:431–438. https://doi.org/10.1111/bjd.15122
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and staging of rosacea. J Am Acad Dermatol 46:584–587. https://doi.org/10.1067/mjd.2002.120625
Thomas K, Yelverton CB, Yentzer BA, Balkrishnan R, Fleischer AB Jr, Feldman SR (2009) The cost-effectiveness of rosacea treatments. J Dermatolog Treat 20:72–75. https://doi.org/10.1080/09546630802314662
Elewski BE, Fleischer AB Jr, Pariser DM (2003) A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 139:1444–1450. https://doi.org/10.1001/archderm.139.11.1444
Kang CN, Shah M, Tan J (2021) Rosacea: an update in diagnosis, classification and management. Skin Therapy Lett 26:1–8
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L, Stein-Gold L, Berson D, Zaenglein A (2013) Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis 92:277–284
Del Rosso JQ, Tanghetti EA, Baldwin HE, Rodriguez DA, Ferrusi IL (2017) The burden of illness of erythematotelangiectatic rosacea and papulopustular rosacea: findings from a web-based survey. J Clin Aesthet Dermatol 10:17–31
Tan ST, Bialostocki A, Armstrong JR (2004) Pulsed dye laser therapy for rosacea. Br J Plast Surg 57:303–310. https://doi.org/10.1016/j.bjps.2004.02.011
Kwon SH, Jeong MY, Park KC, Youn SW, Huh CH, Na JI (2014) A new therapeutic option for facial seborrhoeic dermatitis: indole-3-acetic acid photodynamic therapy. J Eur Acad Dermatol Venereol 28:94–99. https://doi.org/10.1111/jdv.12070
Sun Y, Chen LH, Zhang YH, Gao XH, Wu Y, Chen HD (2019) Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with rosacea. J Cosmet Laser Ther 21:196–200. https://doi.org/10.1080/14764172.2018.1502455
Piwnica D, Rosignoli C, de Menonville ST, Alvarez T, Nollet MS, Roye O, Jomard A, Aubert J (2014) Vasoconstriction and anti-inflammatory properties of the selective alpha-adrenergic receptor agonist brimonidine. J Dermatol Sci 75:49–54. https://doi.org/10.1016/j.jdermsci.2014.04.002
Tsunoda K, Akasaka K, Akasaka T, Amano H (2018) Successful treatment of erythematotelangiectatic rosacea with intense pulsed light: report of 13 cases. J Dermatol 45:1113–1116. https://doi.org/10.1111/1346-8138.14513
Nybaek H, Jemec GBE (2005) Photodynamic therapy in the treatment of rosacea. Dermatol 211:135–138. https://doi.org/10.1159/000086443
Katz B, Patel V (2006) Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea. J Drugs Dermatol 5:6–8
Bryld LE, Jemec GBE (2007) Photodynamic therapy in a series of rosacea patients. J Eur Acad Dermatol Venereol 21:1199–1202. https://doi.org/10.1111/j.1468-3083.2007.02219.x
Kassir R, Kolluru A, Kassir M (2011) Intense pulsed light for the treatment of rosacea and telangiectasias. J Cosmet Laser Ther 13:216–222. https://doi.org/10.3109/14764172.2011.613480
Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M (2008) Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol 159:628–632. https://doi.org/10.1111/j.1365-2133.2008.08702.x
Piccolo D, Di Marcantonio D, Crisman G, Cannarozzo G, Sannino M, Chiricozzi A, Chimenti S (2014) Unconventional use of intense pulsed light. Biomed Res Int 2014:618206. https://doi.org/10.1155/2014/618206
Zhang Y, Jiang S, Lu Y, Yan W, Yan H, Xu Y, Xu T, Li Y, Geng L, Gao X, Chen H (2020) A decade retrospective study of light/laser devices in treating nasal rosacea. J Dermatolog Treat 31:84–90. https://doi.org/10.1080/09546634.2019.1580669
Wu HE, Liu YB, Cui L, Xu GJ, Sun XD (2021) A prospective study of the effect of fire micro-needling plus 5% topical ALA-PDT for the treatment of dissecting cellulitis of the scalp. Photodiagnosis Photodyn Ther 35:102396. https://doi.org/10.1016/j.pdpdt.2021.102396
NNakai K, Tsuruta D (2021) What are reactive oxygen species, free radicals, and oxidative stress in skin diseases? Int J Mol Sci 22(19):10799. https://doi.org/10.3390/ijms221910799
Funding
This work was supported by the National Natural Science Foundation of China (Grant number 82103758).
Author information
Authors and Affiliations
Contributions
NaiJia Bao made the acquisition, analysis, and interpretation of data and drafted the work; TianShu Gu and Jing Zeng made analysis and interpretation of data for the work; Yan Wu and Yan Sun designed and revised the work; XingHua Gao and HongDuo Chen revised the work. All authors finally approved the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bao, N., Gu, T., Zeng, J. et al. Combined therapy of 5-aminolevulinic acid photodynamic therapy and intense pulsed light for rosacea. Lasers Med Sci 38, 17 (2023). https://doi.org/10.1007/s10103-022-03685-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10103-022-03685-y